Cyclohexapeptides as selective somatostatin SST5 receptor agonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11987648
APP PUB NO 20210363188A1
SERIAL NO

17284399

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosures herein relate to novel compounds of formula (1):(1) and salts thereof, wherein W, X, Y, Z, m, n, q, R1, R2, R3, R4, R5 and R6 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with somatostatin receptors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NXERA PHARMA UK LIMITEDCAMBRIDGE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bortolato, Andrea Cambridge, GB 16 42
Brown, Giles Albert Cambridge, GB 72 817
Congreve, Miles Stuart Cambridge, GB 132 1216
Paul, Rebecca Cambridge, GB 10 0
Scully, Conor Cambridge, GB 8 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 21, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 21, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 21, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00